Search Results - "Pinney, J.H."

  • Showing 1 - 5 results of 5
Refine Results
  1. 1

    A matched comparison of cyclophosphamide, bortezomib and dexamethasone (CVD) versus risk-adapted cyclophosphamide, thalidomide and dexamethasone (CTD) in AL amyloidosis by Venner, C P, Gillmore, J D, Sachchithanantham, S, Mahmood, S, Lane, T, Foard, D, Rannigan, L, Gibbs, S D J, Pinney, J H, Whelan, C J, Lachmann, H J, Hawkins, P N, Wechalekar, A D

    Published in Leukemia (01-12-2014)
    “…Despite improvements in therapy amyloid light-chain (AL) amyloidosis, there are few studies comparing different regimens. Here we present a matched comparison…”
    Get full text
    Journal Article
  2. 2

    Solid Organ Transplantation in AL Amyloidosis by Sattianayagam, P. T., Gibbs, S. D. J., Pinney, J. H., Wechalekar, A. D., Lachmann, H. J., Whelan, C. J., Gilbertson, J. A., Hawkins, P. N., Gillmore, J. D.

    Published in American journal of transplantation (01-09-2010)
    “…Vital organ failure remains common in AL amyloidosis. Solid organ transplantation is contentious because of the multisystem nature of this disease and risk of…”
    Get full text
    Journal Article
  3. 3

    Renal Transplantation in Systemic Amyloidosis—Importance of Amyloid Fibril Type and Precursor Protein Abundance by Pinney, J. H., Lachmann, H. J., Sattianayagam, P. T., Gibbs, S. D. J., Wechalekar, A. D., Venner, C. P., Whelan, C. J., Gilbertson, J. A., Rowczenio, D., Hawkins, P. N., Gillmore, J. D.

    Published in American journal of transplantation (01-02-2013)
    “…Renal transplantation remains contentious in patients with systemic amyloidosis due to the risk of graft loss from recurrent amyloid and progressive disease…”
    Get full text
    Journal Article
  4. 4

    A matched comparison of cyclophosphamide, bortezomib and dexamethasone in AL amyloidosis by Venner, C.P, Gillmore, J.D, Sachchithanantham, S, Mahmood, S, Lane, T, Foard, D, Rannigan, L, Gibbs, S.D.J, Pinney, J.H, Whelan, C.J, Lachmann, H.J, Hawkins, P.N, Wechalekar, A.D

    Published in Leukemia (01-12-2014)
    “…Despite improvements in therapy amyloid light-chain (AL) amyloidosis, there are few studies comparing different regimens. Here we present a matched comparison…”
    Get full text
    Journal Article
  5. 5